Physician profile
Elliott Lampert
NPI 1801883103
$1,540.47
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $115 · 2022: $529 · 2023: $243 · 2024: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471 · Long Term Medical Supply Or Device Loan: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.50 |
| Long Term Medical Supply Or Device Loan | $263.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $303.95 | 2024 | Integra, Acell, Primatrix |
| Cardiovascular Systems INC. | $205.72 | 2019-2021 | |
| Organogenesis INC. | $175.44 | 2022-2024 | Puraply Am |
| Aroa Biosurgery Incorporated | $141.77 | 2023 | |
| Grt US Holding, INC. | $128.00 | 2022 | |
| Nevro Corp. | $120.82 | 2022 | |
| Ets Wound Care LLC | $101.28 | 2023 | |
| Kci USA, INC. | $99.96 | 2022 | |
| Abbvie INC. | $90.35 | 2022 | |
| Hnm Stainless, LLC | $87.50 | 2024 | |
| Medtronic Vascular, INC. | $71.49 | 2019 | |
| Mimedx Group, INC. | $14.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Lampert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.